3 Biotechs With Huge FDA Decisions in June

Three biotechs that have reached this critical milestone with their respective new drugs and await key FDA approval decisions in June are Array BioPharma (NASDAQ:ARRY), GW Pharmaceuticals (NASDAQ:GWPH), and Incyte (NASDAQ:INCY).